Abstract:Background: Vitiligo is characterized by the loss and/or dysfunction of melanocytes in the skin and has a profound impact on the social interactions of patients. Although there are many treatment options for vitiligo, the outcome is frequently unsatisfactory, especially for patients with stable vitiligo. Objectives: To study the biological properties of melanocytes derived from human hair follicles and to observe the efficacy of using transplants of autologous hair follicle cells to treat patients with stable vitiligo. Methods: From February 2014 to March 2017, 26 patients with stable vitiligo, who were refractory to all current routine therapy, underwent treatment with transplanted autologous hair follicle cells. The skin graft from each patient's occipital region was trimmed to remove excess adipose tissue and some of the upper part of the dermis. The remaining tissue, including hair follicles and dermal papillae, was cut into pieces and incubated in collagenase type IV and then in trypsin-ethylenediaminetetraacetic acid solutions. The cells were recovered, resuspended in the patient's own serum and then applied to the recipient area. Clinical observations continued for 6 months to 1 year. Laboratory experiments were also performed during this time on scalp specimens obtained from normal human volunteers. Cells migrating from the outer root sheath and the dermal papillae at various times of culture were observed using a microscope. Results: Most of the repigmentation in the vitiligo areas appeared within 8 weeks of transplantation of autologous hair follicle cells. Early skin repigmentation was not uniform and appeared more repigmented than the surrounding normal skin. As time went by, the repigmentation became more obvious and matched the color of the skin around the lesion. Most of the pigmentation presented as a diffuse pattern and was not localized around the hair follicles. Among the 26 patients, 9 (34.6%) achieved excellent repigmentation, while 13 (50.0%) had good, 3 (11.5%) fair and 1 (3.9%) poor repigmentation. During the follow-up visit at 1 year, no excess hair growth was observed in the recipient areas and there was no scarring or ulcer formation in the donor or recipient areas. In the experimental part of the study, many keratinocytes, melanocytes and fibroblasts migrated from the adherent outer root sheath. In later subcultures using a specialized medium, pure melanocytes were obtained that had a strong proliferative capacity and had bipolar or poly-dendritic shapes. On the other hand, cells from the dermal papillae grew radially in primary culture and were almost fibroblast-like. However, a few bipolar melanocytes appeared in the later stage of culture. Conclusions: The results of our study show that transplantation of autologous hair follicle cells is a simple and effective method to treat patients with stable vitiligo. Hair follicles (especially the outer root sheath) harbor many melanocytes with potential proliferative ability. Limitations: There are a few limitations of the present study: a small sample size, a short follow-up period, no cell counting or viability testing.

Establishment of a promising vitiligo mouse model for pathogenesis and treatment studies

From Mice to Men: an Assessment of Preclinical Model Systems for the Study of Vitiligo

Direct Reprogramming of Mouse Fibroblasts into Melanocytes.

Repigmentation by combined narrow‑band ultraviolet B/adipose‑derived stem cell transplantation in the mouse model: Role of Nrf2/HO‑1‑mediated Ca2+ homeostasis

Animal models unraveling the complexity of vitiligo pathogenesis

Sexual dimorphism in melanocyte stem cell behavior reveals combinational therapeutic strategies for cutaneous repigmentation

Optimization of Monobenzone-Induced Vitiligo Mouse Model by the Addition of Chronic Stress

Biomimetic Melanosomes Promote Orientation-Selective Delivery and Melanocyte Pigmentation in the H2O2-Induced Vitiligo Mouse Model

1205 MIF-inhibition Ameliorates Vitiligo by Suppressing CD8+T Cell Activation and Proliferation

Experimental study and clinical observations of autologous hair follicle cell transplants to treat stable vitiligo

Vitiligo: From Pathogenesis to Treatment

Vitiligo: An immune disease and its emerging mesenchymal stem cell therapy paradigm

122 Normalization of CD8+ T cell metabolism inhibits and reverses depigmentation in vitiligo

Understanding mechanisms of autoimmunity through translational research in vitiligo

The Influence of 308 nm Excimer Light on Treg and Th17 Cells in Guinea Pig Model of Vitiligo

CCL17‐CCR4 Axis Contributes to the Onset of Vitiligo in Mice

Vitiligo: An Autoimmune Skin Disease and its Immunomodulatory Therapeutic Intervention

Trends in Regenerative Medicine: Repigmentation in Vitiligo Through Melanocyte Stem Cell Mobilization

Melanocytes Derived from Mouse Hair Follicles: A Novel Study Model to Assess Pigmentation Disorders.

Identification of the Role of Wnt/-Catenin Pathway Through Integrated Analyses and in vivo Experiments in Vitiligo

MIF Inhibition Alleviates Vitiligo Progression by Suppressing CD8+ T Cell Activation and Proliferation